Literature DB >> 29091199

Monitoring microevolution of OXA-48-producing Klebsiella pneumoniae ST147 in a hospital setting by SMRT sequencing.

Andreas E Zautner1, Boyke Bunk2, Yvonne Pfeifer3, Cathrin Spröer2, Utz Reichard4, Helmut Eiffert1, Simone Scheithauer4, Uwe Groß1, Jörg Overmann2, Wolfgang Bohne1.   

Abstract

Objectives: Carbapenemase-producing Klebsiella pneumoniae pose an increasing risk for healthcare facilities worldwide. A continuous monitoring of ST distribution and its association with resistance and virulence genes is required for early detection of successful K. pneumoniae lineages. In this study, we used WGS to characterize MDR blaOXA-48-positive K. pneumoniae isolated from inpatients at the University Medical Center Göttingen, Germany, between March 2013 and August 2014.
Methods: Closed genomes for 16 isolates of carbapenemase-producing K. pneumoniae were generated by single molecule real-time technology using the PacBio RSII platform.
Results: Eight of the 16 isolates showed identical XbaI macrorestriction patterns and shared the same MLST, ST147. The eight ST147 isolates differed by only 1-25 SNPs of their core genome, indicating a clonal origin. Most of the eight ST147 isolates carried four plasmids with sizes of 246.8, 96.1, 63.6 and 61.0 kb and a novel linear plasmid prophage, named pKO2, of 54.6 kb. The blaOXA-48 gene was located on a 63.6 kb IncL plasmid and is part of composite transposon Tn1999.2. The ST147 isolates expressed the yersinabactin system as a major virulence factor. The comparative whole-genome analysis revealed several rearrangements of mobile genetic elements and losses of chromosomal and plasmidic regions in the ST147 isolates. Conclusions: Single molecule real-time sequencing allowed monitoring of the genetic and epigenetic microevolution of MDR OXA-48-producing K. pneumoniae and revealed in addition to SNPs, complex rearrangements of genetic elements.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29091199     DOI: 10.1093/jac/dkx216

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

Review 1.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

2.  Characterization of Extensively Drug-Resistant or Pandrug-Resistant Sequence Type 147 and 101 OXA-48-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Patients in an Intensive Care Unit.

Authors:  Kalliope Avgoulea; Vincenzo Di Pilato; Olympia Zarkotou; Samanta Sennati; Leda Politi; Antonio Cannatelli; Katerina Themeli-Digalaki; Tommaso Giani; Athanassios Tsakris; Gian Maria Rossolini; Spyros Pournaras
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 3.  Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147.

Authors:  Gisele Peirano; Liang Chen; Barry N Kreiswirth; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

4.  Structural Genomics of repA, repB 1-Carrying IncFIB Family pA1705-qnrS, P911021-tetA, and P1642-tetA, Multidrug-Resistant Plasmids from Klebsiella pneumoniae.

Authors:  Amina Nazir; Yachao Zhao; Manli Li; Rakia Manzoor; Rana Adnan Tahir; Xianglilan Zhang; Hong Qing; Yigang Tong
Journal:  Infect Drug Resist       Date:  2020-06-22       Impact factor: 4.003

Review 5.  Phage Therapy: What Have We Learned?

Authors:  Andrzej Górski; Ryszard Międzybrodzki; Małgorzata Łobocka; Aleksandra Głowacka-Rutkowska; Agnieszka Bednarek; Jan Borysowski; Ewa Jończyk-Matysiak; Marzanna Łusiak-Szelachowska; Beata Weber-Dąbrowska; Natalia Bagińska; Sławomir Letkiewicz; Krystyna Dąbrowska; Jacques Scheres
Journal:  Viruses       Date:  2018-05-28       Impact factor: 5.048

6.  An MLST approach to support tracking of plasmids carrying OXA-48-like carbapenemase.

Authors:  Carina Brehony; Elaine McGrath; Wendy Brennan; Alma Tuohy; Thomas Whyte; Sylvain Brisse; Martin Maiden; Keith Jolley; Dearbháile Morris; Martin Cormican
Journal:  J Antimicrob Chemother       Date:  2019-07-01       Impact factor: 5.790

7.  Clonal Dissemination of KPC-2, VIM-1, OXA-48-Producing Klebsiella pneumoniae ST147 in Katowice, Poland.

Authors:  Dorota Ochońska; Hanna Klamińska-Cebula; Anna Dobrut; Małgorzata Bulanda; Monika Brzychczy-Włoch
Journal:  Pol J Microbiol       Date:  2021-03-19

8.  Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008-2014.

Authors:  Laura Becker; Martin Kaase; Yvonne Pfeifer; Stephan Fuchs; Annicka Reuss; Anja von Laer; Muna Abu Sin; Miriam Korte-Berwanger; Sören Gatermann; Guido Werner
Journal:  Antimicrob Resist Infect Control       Date:  2018-05-02       Impact factor: 4.887

9.  Tracking microevolution events among ST11 carbapenemase-producing hypervirulent Klebsiella pneumoniae outbreak strains.

Authors:  Ning Dong; Xuemei Yang; Rong Zhang; Edward Wai-Chi Chan; Sheng Chen
Journal:  Emerg Microbes Infect       Date:  2018-08-12       Impact factor: 7.163

10.  Detection of a New Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Klebsiella pneumoniae Strain at a German University Hospital.

Authors:  Julian Schwanbeck; Wolfgang Bohne; Ufuk Hasdemir; Uwe Groß; Yvonne Pfeifer; Boyke Bunk; Thomas Riedel; Cathrin Spröer; Jörg Overmann; Hagen Frickmann; Andreas E Zautner
Journal:  Microorganisms       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.